DBT (ALDBT.PA) Fundamental Analysis & Valuation

EPA:ALDBT • FR001400LO86

Current stock price

0.041 EUR
0 (-5.75%)
Last:

This ALDBT.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. ALDBT.PA Profitability Analysis

1.1 Basic Checks

  • In the past year ALDBT has reported negative net income.
  • ALDBT had a negative operating cash flow in the past year.
  • In the past 5 years ALDBT always reported negative net income.
  • In the past 5 years ALDBT always reported negative operating cash flow.
ALDBT.PA Yearly Net Income VS EBIT VS OCF VS FCFALDBT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

  • ALDBT's Return On Assets of -14.55% is on the low side compared to the rest of the industry. ALDBT is outperformed by 82.19% of its industry peers.
  • Looking at the Return On Equity, with a value of -46.17%, ALDBT is doing worse than 82.19% of the companies in the same industry.
Industry RankSector Rank
ROA -14.55%
ROE -46.17%
ROIC N/A
ROA(3y)-23.56%
ROA(5y)-31%
ROE(3y)-52.67%
ROE(5y)-63.14%
ROIC(3y)N/A
ROIC(5y)N/A
ALDBT.PA Yearly ROA, ROE, ROICALDBT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 1K

1.3 Margins

  • With a Gross Margin value of 31.98%, ALDBT perfoms like the industry average, outperforming 41.10% of the companies in the same industry.
  • In the last couple of years the Gross Margin of ALDBT has grown nicely.
  • ALDBT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 31.98%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y1.62%
ALDBT.PA Yearly Profit, Operating, Gross MarginsALDBT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. ALDBT.PA Health Analysis

2.1 Basic Checks

  • ALDBT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for ALDBT has been increased compared to 1 year ago.
  • Compared to 5 years ago, ALDBT has less shares outstanding
  • Compared to 1 year ago, ALDBT has a worse debt to assets ratio.
ALDBT.PA Yearly Shares OutstandingALDBT.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
ALDBT.PA Yearly Total Debt VS Total AssetsALDBT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

  • ALDBT has an Altman-Z score of -0.78. This is a bad value and indicates that ALDBT is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -0.78, ALDBT is doing worse than 83.56% of the companies in the same industry.
  • There is no outstanding debt for ALDBT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.78
ROIC/WACCN/A
WACC4.35%
ALDBT.PA Yearly LT Debt VS Equity VS FCFALDBT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

2.3 Liquidity

  • A Current Ratio of 0.67 indicates that ALDBT may have some problems paying its short term obligations.
  • With a Current ratio value of 0.67, ALDBT is not doing good in the industry: 93.15% of the companies in the same industry are doing better.
  • A Quick Ratio of 0.41 indicates that ALDBT may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.41, ALDBT is not doing good in the industry: 94.52% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.67
Quick Ratio 0.41
ALDBT.PA Yearly Current Assets VS Current LiabilitesALDBT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. ALDBT.PA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 87.59% over the past year.
  • The Revenue for ALDBT has decreased by -18.47% in the past year. This is quite bad
  • Measured over the past years, ALDBT shows a small growth in Revenue. The Revenue has been growing by 1.98% on average per year.
EPS 1Y (TTM)87.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%3.08%
Revenue 1Y (TTM)-18.47%
Revenue growth 3Y32.91%
Revenue growth 5Y1.98%
Sales Q2Q%-29.93%

3.2 Future

  • The Earnings Per Share is expected to grow by 24.42% on average over the next years. This is a very strong growth
  • The Revenue is expected to decrease by -90.45% on average over the next years. This is quite bad
EPS Next Y28.13%
EPS Next 2Y20.08%
EPS Next 3Y24.42%
EPS Next 5YN/A
Revenue Next Year25.09%
Revenue Next 2Y25.88%
Revenue Next 3Y-90.45%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALDBT.PA Yearly Revenue VS EstimatesALDBT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10B 20B 30B
ALDBT.PA Yearly EPS VS EstimatesALDBT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2024 2025 2026 2027 -2K -4K -6K

More info and screens

Find the best growth stocksShow best growing peers

1

4. ALDBT.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ALDBT. In the last year negative earnings were reported.
  • Also next year ALDBT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALDBT.PA Price Earnings VS Forward Price EarningsALDBT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALDBT.PA Per share dataALDBT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3

4.3 Compensation for Growth

  • ALDBT's earnings are expected to grow with 24.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.08%
EPS Next 3Y24.42%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALDBT.PA Dividend Analysis

5.1 Amount

  • No dividends for ALDBT!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALDBT.PA Fundamentals: All Metrics, Ratios and Statistics

DBT

EPA:ALDBT (3/30/2026, 7:00:00 PM)

0.041

0 (-5.75%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.23%
Inst Owner ChangeN/A
Ins Owners0.08%
Ins Owner ChangeN/A
Market Cap685.52K
Revenue(TTM)8.53M
Net Income(TTM)-4.62M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.08
P/FCF N/A
P/OCF N/A
P/B 0.07
P/tB 0.1
EV/EBITDA N/A
EPS(TTM)-0.71
EYN/A
EPS(NY)-3.86
Fwd EYN/A
FCF(TTM)-0.67
FCFYN/A
OCF(TTM)-0.42
OCFYN/A
SpS0.51
BVpS0.6
TBVpS0.41
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -14.55%
ROE -46.17%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 31.98%
FCFM N/A
ROA(3y)-23.56%
ROA(5y)-31%
ROE(3y)-52.67%
ROE(5y)-63.14%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y1.62%
F-Score3
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 259.76%
Cap/Sales 48.8%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.67
Quick Ratio 0.41
Altman-Z -0.78
F-Score3
WACC4.35%
ROIC/WACCN/A
Cap/Depr(3y)433.24%
Cap/Depr(5y)302.25%
Cap/Sales(3y)51%
Cap/Sales(5y)37.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)87.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%3.08%
EPS Next Y28.13%
EPS Next 2Y20.08%
EPS Next 3Y24.42%
EPS Next 5YN/A
Revenue 1Y (TTM)-18.47%
Revenue growth 3Y32.91%
Revenue growth 5Y1.98%
Sales Q2Q%-29.93%
Revenue Next Year25.09%
Revenue Next 2Y25.88%
Revenue Next 3Y-90.45%
Revenue Next 5YN/A
EBIT growth 1Y19.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year39.41%
EBIT Next 3Y26.01%
EBIT Next 5YN/A
FCF growth 1Y-16.03%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-39.36%
OCF growth 3YN/A
OCF growth 5YN/A

DBT / ALDBT.PA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for DBT?

ChartMill assigns a fundamental rating of 2 / 10 to ALDBT.PA.


Can you provide the valuation status for DBT?

ChartMill assigns a valuation rating of 1 / 10 to DBT (ALDBT.PA). This can be considered as Overvalued.


What is the profitability of ALDBT stock?

DBT (ALDBT.PA) has a profitability rating of 1 / 10.


Is the dividend of DBT sustainable?

The dividend rating of DBT (ALDBT.PA) is 0 / 10 and the dividend payout ratio is 0%.